133 related articles for article (PubMed ID: 31036584)
1. Can naproxen slow the progression of Alzheimer disease?
Karceski S; Karceski S
Neurology; 2019 Apr; 92(18):e2181-e2184. PubMed ID: 31036584
[No Abstract] [Full Text] [Related]
2. Author response: INTREPAD: A randomized trial of naproxen to slow progress of presymptomatic Alzheimer disease.
Breitner J; Meyer PF
Neurology; 2020 Mar; 94(13):594. PubMed ID: 32229636
[No Abstract] [Full Text] [Related]
3. Reader response: INTREPAD: A randomized trial of naproxen to slow progress of presymptomatic Alzheimer disease.
Ashford JW
Neurology; 2020 Mar; 94(13):593-594. PubMed ID: 32229635
[No Abstract] [Full Text] [Related]
4. Naproxen for presymptomatic Alzheimer disease: Is this the end, or shall we try again?
Hershey LA; Lipton RB
Neurology; 2019 Apr; 92(18):829-830. PubMed ID: 30952790
[No Abstract] [Full Text] [Related]
5. Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial.
Aisen PS; Schafer KA; Grundman M; Pfeiffer E; Sano M; Davis KL; Farlow MR; Jin S; Thomas RG; Thal LJ;
JAMA; 2003 Jun; 289(21):2819-26. PubMed ID: 12783912
[TBL] [Abstract][Full Text] [Related]
6. Effects of non-steroidal anti-inflammatory drug treatments on cognitive decline vary by phase of pre-clinical Alzheimer disease: findings from the randomized controlled Alzheimer's Disease Anti-inflammatory Prevention Trial.
Leoutsakos JM; Muthen BO; Breitner JC; Lyketsos CG;
Int J Geriatr Psychiatry; 2012 Apr; 27(4):364-74. PubMed ID: 21560159
[TBL] [Abstract][Full Text] [Related]
7. Pass the tablet please.
Czap A
Altern Med Rev; 2003 Aug; 8(3):222. PubMed ID: 12946236
[No Abstract] [Full Text] [Related]
8. Cognitive function over time in the Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT): results of a randomized, controlled trial of naproxen and celecoxib.
; Martin BK; Szekely C; Brandt J; Piantadosi S; Breitner JC; Craft S; Evans D; Green R; Mullan M
Arch Neurol; 2008 Jul; 65(7):896-905. PubMed ID: 18474729
[TBL] [Abstract][Full Text] [Related]
9. Anti-inflammatory drugs fall short in Alzheimer's disease.
Nat Med; 2008 Sep; 14(9):916. PubMed ID: 18776882
[No Abstract] [Full Text] [Related]
10. Can treatment with nonsteroidal anti-inflammatory drugs protect from dementia?
Bregman N; Karni A; Korczyn AD
Arch Neurol; 2009 Apr; 66(4):539-40; author reply 540. PubMed ID: 19364945
[No Abstract] [Full Text] [Related]
11. Meta-analysis: cardiovascular events associated with nonsteroidal anti-inflammatory drugs.
Salpeter SR; Gregor P; Ormiston TM; Whitlock R; Raina P; Thabane L; Topol EJ
Am J Med; 2006 Jul; 119(7):552-9. PubMed ID: 16828623
[TBL] [Abstract][Full Text] [Related]
12. No apparent effect of naproxen on CSF markers of innate immune activation.
Meyer PF; Labonté A; Rosa-Neto P; Poirier J; Breitner JCS;
Ann Clin Transl Neurol; 2019 Jun; 6(6):1127-1133. PubMed ID: 31211178
[TBL] [Abstract][Full Text] [Related]
13. Extended results of the Alzheimer's disease anti-inflammatory prevention trial.
Breitner JC; Baker LD; Montine TJ; Meinert CL; Lyketsos CG; Ashe KH; Brandt J; Craft S; Evans DE; Green RC; Ismail MS; Martin BK; Mullan MJ; Sabbagh M; Tariot PN;
Alzheimers Dement; 2011 Jul; 7(4):402-11. PubMed ID: 21784351
[TBL] [Abstract][Full Text] [Related]
14. Nonsteroidal drugs and Alzheimer's disease.
Press D
N Engl J Med; 2002 Apr; 346(15):1171-3. PubMed ID: 11951859
[No Abstract] [Full Text] [Related]
15. Naproxen and celecoxib do not prevent AD in early results from a randomized controlled trial.
; Lyketsos CG; Breitner JC; Green RC; Martin BK; Meinert C; Piantadosi S; Sabbagh M
Neurology; 2007 May; 68(21):1800-8. PubMed ID: 17460158
[TBL] [Abstract][Full Text] [Related]
16. Gastroprotective and ulcer healing effects of nitric oxide-releasing non-steroidal anti-inflammatory drugs.
Brzozowski T; Konturek PC; Konturek SJ; Sliwowski Z; Drozdowicz D; Kwiecień S; Pajdo R; Ptak A; Pawlik M; Hahn E
Dig Liver Dis; 2000 Oct; 32(7):583-94. PubMed ID: 11142556
[TBL] [Abstract][Full Text] [Related]
17. NSAIDs and hypertension.
Aisen PS; Schafer K; Grundman M; Thomas R; Thal LJ
Arch Intern Med; 2003 May; 163(9):1115; author reply 1115-6. PubMed ID: 12742818
[No Abstract] [Full Text] [Related]
18. NSAIDs and Alzheimer's disease: how far to generalise from trials?
Breitner JC
Lancet Neurol; 2003 Sep; 2(9):527. PubMed ID: 12941571
[No Abstract] [Full Text] [Related]
19. Effect of NSAIDs on risk of Alzheimer's disease: confounding factors were not discussed.
Robertson M
BMJ; 2003 Sep; 327(7417):751; author reply 751-2. PubMed ID: 14512494
[No Abstract] [Full Text] [Related]
20. Non-steroidal anti-inflammatory drugs (NSAIDs) for chronic non-cancer pain in children and adolescents.
Eccleston C; Cooper TE; Fisher E; Anderson B; Wilkinson NM
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD012537. PubMed ID: 28770976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
